Products
Online Inquiry
8-Epidiosbulbin E acetate
Cat. No.:
0225LY-1319
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
8-Epidiosbulbin E acetate displays broad-spectrum plasmid-curing properties, making it effective against multidrug-resistant bacteria, including vancomycin-resistant strains.
Synonym:
91095-48-6; [(1R,2S,3S,5S,8S,10S,11R,13R)-8-(furan-3-yl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.02,11.05,10]hexadecan-3-yl] acetate; [(1R,2S,3S,5S,8S,10S,11R,13R)-8-(uran-3-yl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.02,11.05,10]hexadecan-3-yl] acetate
CAS No.:
91095-48-6
Compound CID:
134715250
Formula:
C21H24O7
Formula Weight:
388.41
Specification
Relative Density:
1.34 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
8-Epidiosbulbin E acetate can be used in pharmacological studies to examine the induction of liver injury in toxicity models or to study natural terpene bioactivity.
Library Information
Target:
Bacterial protein
Pathways:
Microbiology/Virology
Plate Number:
AOCL-17
Plate Location:
h6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
55 mg/mL; 141.6 mM
